跳至主要内容
临床试验/KCT0005010
KCT0005010
已完成
未知

The Relationship between cardiovascular disease and Brachial-ankle Pulse Wave Velocity(baPWV) in Patients with Type 2 Diabetes (REBOUND study)

Pusan National University Hospital0 个研究点目标入组 2,333 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Pusan National University Hospital
入组人数
2333
状态
已完成
最后更新
5年前

概览

简要总结

We found that a high-baPWV can predict all-cause and cause-specific mortality in subjects with type 2 diabetes. Our study is the first using a long-term and large-scale prospective cohort to present the appropriate baPWV cutoff point for cause-specific mortality, and demonstrates the predictive role of baPWV for cancer prognosis independent of conventional risk factors in people with type 2 diabetes. The measurement of baPWV as a noninvasive tool for arterial stiffness is useful for assessing mortality risk and, furthermore, 1,900 cm/s may be considered the optimal value for mortality risk assessment in type 2 diabetic patients.

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
5年前
研究类型
Observational Study
性别
All

研究者

入排标准

入选标准

  • The inclusion criteria for patients
  • (i) patients with type 2 diabetes who were 30 years of age or older
  • (ii) baseline baPWV measured

排除标准

  • (i) type 1 diabetes mellitus;
  • (ii) an ankle brachial index (ABI) of \<0\.9
  • (iii) severe symptoms and/or signs of Cardiovascular disease
  • (iv) hospitalization within the previous three months due to acute myocardial infarction, stroke, or heart failure;
  • (v) chronic kidney disease (serum creatinine levels \>2\.0 mg/dL)

结局指标

主要结局

未指定

相似试验

Unknown
不适用
Relationship Between Morbimortality and Basal Activated Clotting Time (ACT) in Patients Undergoing Vascular SurgeryArtery Disease, PeripheralAortic DiseasesCarotid Artery DiseasesOther Disease
NCT04703582Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau30
进行中(未招募)
1 期
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-CZVIVUS, Inc.16,000
进行中(未招募)
1 期
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-SKVIVUS, Inc.16,000
进行中(未招募)
不适用
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-003946-34-GBVIVUS, Inc.16,000
已完成
不适用
Association Between Cardiovascular Diseases and Mental IllnessCardiovascular DiseasesMental Disorder
NCT06239246Ningbo No. 1 Hospital400